Patents by Inventor Harry Oken

Harry Oken has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROPHYLACTIC DOCOSAHEXAENOIC ACID THERAPY FOR PATIENTS WITH SUBCLINICAL INFLAMMATION
    Publication number: 20090203655
    Abstract: This invention is directed to methods and compositions which impede the development and progression of diseases associated with subclinical inflammation. Subclinical inflammation is commonly associated with atherosclerotic cardiovascular disease, coronary disease or cerebrovascular disease. The methods and compositions of the invention are also particularly suited to providing therapy for subclinical inflammation in diabetic and prediabetic patients. Methods of the invention comprise administration of DHA alone and in combination with antiplatelet drugs.
    Type: Application
    Filed: February 3, 2009
    Publication date: August 13, 2009
    Applicant: Martek Biosciences Corporation
    Inventors: Linda Arterburn, James Hoffman, Harry Oken, Mary Van Elswyk
  • Prophylactic docosahexaenoic acid therapy for patients with subclinical inflammation
    Publication number: 20060069159
    Abstract: This invention is directed to methods and compositions which impede the development and progression of diseases associated with subclinical inflammation. Subclinical inflammation is commonly associated with atherosclerotic cardiovascular disease, coronary disease or cerebrovascular disease. The methods and compositions of the invention are also particularly suited to providing therapy for subclinical inflammation in diabetic and prediabetic patients. Methods of the invention comprise administration of DHA alone and in combination with antiplatelet drugs.
    Type: Application
    Filed: September 12, 2005
    Publication date: March 30, 2006
    Applicant: Martek Biosciences Corporation
    Inventors: Linda Arterburn, James Hoffman, Harry Oken, Mary Van Elswyk
  • Prophylactic docosahexaenoic acid therapy for patients with subclinical inflammation
    Publication number: 20040106584
    Abstract: This invention is directed to methods and compositions which impede the development and progression of diseases associated with subclinical inflammation. Subclinical inflammation is commonly associated with atherosclerotic cardiovascular disease, coronary disease or cerebrovascular disease. The methods and compositions of the invention are also particularly suited to providing therapy for subclinical inflammation in diabetic and prediabetic patients. Methods of the invention comprise administration of DHA alone and in combination with antiplatelet drugs.
    Type: Application
    Filed: September 29, 2003
    Publication date: June 3, 2004
    Inventors: Linda Arterburn, James Hoffman, Harry Oken, Mary Van Elswyk
  • Glycemic control for prediabetes and/or diabetes Type II using docosahexaenoic acid
    Publication number: 20040092590
    Abstract: This invention is directed to methods of treating patients with metabolic syndrome, prediabetes and/or Type II diabetes mellitus by administering docosahexaenoic acid (DHA) alone or in combination with diabetes-related medications.
    Type: Application
    Filed: September 29, 2003
    Publication date: May 13, 2004
    Inventors: Linda Arterburn, Diane Benisek, James Hoffman, Harry Oken, Mary Van Elswyk